780 likes | 800 Views
Explore the benefits and risks of blood transfusions with a focus on optimal strategies. Learn about liberal versus restrictive transfusion policies, outcomes, and key research findings in cardiac and critical care settings. Understand the impact on patient mortality, organ failures, and quality of life, drawing insights from major studies like TRICC, FOCUS, and RELIEVE. Delve into considerations for patients with Ischaemic Heart Disease (IHD) based on studies like MINT and TRACS. Enhance your knowledge of transfusion protocols for specific conditions such as Upper GI bleeds. This holistic approach aims to foster informed decision-making in clinical practice.
E N D
Blood Transfusion Consultant CPD, November 23rd 2016
Blood is good DO2 = CO x CaO2
Blood is bad Pull out Betty! You’ve hit an artery
Blood is bad Infections Transfusion reactions TRALI TACO Chemical effects due to storage Microcirculation Immunomodulation
Blood is bad Infections Transfusion reactions TRALI TACO Chemical effects due to storage Microcirculation Immunomodulation
Happy medium? Restrictive transfusion The policy of giving blood only when benefits are deemed to outweigh potential risks
The evidence Restrictive vs liberal transfusion strategies 7 key RCTs General / critical care population Cardiac patients [TBI and SAH]
The TRICC study • LIBERAL • Hb 100 -120 • RESTRICTIVE • Hb 70 -90 • OUTCOMES • Death at 30 days & 60 days, organ failures
The TRICC study • LIBERAL • Hb 107 ± 7 (5.6 ± 5.3) • RESTRICTIVE (2.6 ± 4.1) • Hb 85 ± 7 • P<0.01
The FOCUS study 2016 pts >50yrs IHD or risk factors Hb <100 ♯ hip
The FOCUS study • LIBERAL • Hb >100 • RESTRICTIVE • Hb < 80 or signs & symptoms • OUTCOMES • Death at 60 days or inability to walk >10ft
The RELIEVE study >55yrs CCM
The RELIEVE study • LIBERAL • Hb>90 (91-110) • RESTRICTIVE • Hb>70 (71-90) • OUTCOMES • Difference in mean Hb, mortality, adverse events, HRQoL
The RELIEVE study No significant difference in mortality or any of the other outcome measures
IHD pts Am Heart Journal 2011; 162:300
IHD pts • Hospital-acquired anemia was defined as development of new anemia during hospitalization using age, gender, and race specific criteria • Mild – less than normal - >110 • Moderate – 90-110 • Severe - <90
The MINT study STEMI Non STEMI Unstable angina Cardiac catheter Hb<100
The MINT study • LIBERAL • Hb >100 • RESTRICTIVE • Symptomatic • Hb < 80 • OUTCOMES • Death, MI, unscheduled revascularisation
The TRACS study • LIBERAL • Ht >30 • RESTRICTIVE • Ht >24 • OUTCOMES • Death, severe morbidity (CVS, RS, Renal)
Upper GI bleed pts • LIBERAL • Hb 90 -110 • RESTRICTIVE • Hb 70 -90 • OUTCOMES • Death at 45 days, re-bleed, in hospital complications
Upper GI bleed pts No transfusion 51% vs 14%